Lyra Therapeutics, Inc.'s (NASDAQ:LYRA) market cap dropped US$20m last week; Private equity firms bore the brunt

Key Insights Lyra Therapeutics' significant private equity firms ownership suggests that the key decisions are...

Related Keywords

,Perceptive Advisors ,Lyra Therapeutics Inc ,Armistice Capital ,Lyra Therapeutics ,Bridge Venture Partners ,Private Equity Firms ,Institutional Investors ,Private Equity ,Shareholders ,